Malaria, primigravidae, and antibodies: Knowledge gained and future perspectives

Trends in Parasitology

Volumn 30, Issue 2, 2014, Pages 85-94

  Ataíde, Ricardo ^a,d   Mayor, Alfredo ^b,c   Rogerson, Stephen J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF BARCELONA   (Spain)

^c Manhiça Health Research Center   (Mozambique)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Antibodies; Epidemiology; Malaria; Pregnancy; Primigravidae; Serology; Surveillance; VAR2CSA

Indexed keywords

ANTIBODY; APICAL MEMBRANE ANTIGEN 1; CHONDROITIN 4 SULFATE; GAMMA INTERFERON; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 2; INTERLEUKIN 4; MEROZOITE SURFACE PROTEIN 1;

ANTIBODY PRODUCTION; ANTIBODY RESPONSE; CELL PROLIFERATION; CELLULAR IMMUNITY; CHEMOLUMINESCENCE; CYTOKINE PRODUCTION; DISEASE TRANSMISSION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOASSAY; IMMUNOFLUORESCENCE TEST; LOW BIRTH WEIGHT; MALARIA FALCIPARUM; MULTIGRAVIDA; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHAGOCYTOSIS; PLASMODIUM FALCIPARUM; PREGNANCY OUTCOME; PRIMIGRAVIDA; REVIEW; SEROCONVERSION; SEROLOGY; TROPHOBLAST;

PLASMODIUM FALCIPARUM;

ANTIBODIES; EPIDEMIOLOGY; MALARIA; PREGNANCY; PRIMIGRAVIDAE; SEROLOGY; SURVEILLANCE; VAR2CSA;

ANTIBODIES, PROTOZOAN; FEMALE; HUMANS; MALARIA, FALCIPARUM; PARITY; PLASMODIUM FALCIPARUM; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC;

EID: 84893023037     PISSN: 14714922     EISSN: 14715007     Source Type: Journal    
DOI: 10.1016/j.pt.2013.12.007     Document Type: Review

References (74)

1. Kulcsar D. Effect of malaria on pregnancy. Can. Med. Assoc. J. 1947, 57:332-337.
2. Spitz A.J. Malaria infection of the placenta and its influence on the incidence of prematurity in eastern Nigeria. Bull. World Health Organ. 1959, 21:242-244.
3. Jilly P. Anaemia in parturient women, with special reference to malaria infection of the placenta. Ann. Trop. Med. Parasitol. 1969, 63:109-116.
4. Williams A.I., McFarlane H. Distribution of malarial antibody in maternal and cord sera. Arch. Dis. Child. 1969, 44:511-514.
5. Cohen S., et al. Mechanisms of immunity to malaria. Bull. World Health Organ. 1974, 50:251-257.
6. Cohen S., et al. Gamma-globulin and acquired immunity to human malaria. Nature 1961, 192:733-737.
7. Campbell C.C., et al. Seroepidemiological studies of malaria in pregnant women and newborns from coastal El Salvador. Am. J. Trop. Med. Hyg. 1980, 29:151-157.
8. Ibeziako P.A., Williams A.I. The effect of malarial chemoprophylaxis on immunoglobulin levels of pregnant Nigerian women and the newborn. Br. J. Obstet. Gynaecol. 1980, 87:976-982.
9. Brabin B.J. An analysis of malaria in pregnancy in Africa. Bull. World Health Organ. 1983, 61:1005-1016.
10. Deloron P., et al. Serological reactivity to the ring-infected erythrocyte surface antigen and circumsporozoite protein in gravid and nulligravid women infected with Plasmodium falciparum. Trans. R. Soc. Trop. Med. Hyg. 1989, 83:58-62.
11. Riley E.M., et al. Suppression of cell-mediated immune responses to malaria antigens in pregnant Gambian women. Am. J. Trop. Med. Hyg. 1989, 40:141-144.
12. Mvondo J.L., et al. Malaria and pregnancy in Cameroonian women. Naturally acquired antibody responses to asexual blood-stage antigens and the circumsporozoite protein of Plasmodium falciparum. Trans. R. Soc. Trop. Med. Hyg. 1992, 86:486-490.
13. Brabin L., Brabin B.J. Parasitic infections in women and their consequences. Adv. Parasitol. 1992, 31:1-81.
14. Desowitz R.S., et al. Plasmodium falciparum-specific immunoglobulin G (IgG), IgM, and IgE antibodies in paired maternal-cord sera from east Sepik Province, Papua New Guinea. Infect. Immun. 1993, 61:988-993.
15. Rasheed F.N., et al. Suppressed peripheral and placental blood lymphoproliferative responses in first pregnancies: relevance to malaria. Am. J. Trop. Med. Hyg. 1993, 48:154-160.
16. Vleugels M.P., et al. Cortisol and loss of malaria immunity in human pregnancy. Br. J. Obstet. Gynaecol. 1987, 94:758-764.
17. Rasheed F.N., et al. Relationships between maternal malaria and malarial immune responses in mothers and neonates. Parasite Immunol. 1995, 17:1-10.
18. Fievet N., et al. Malaria and pregnancy in Cameroonian primigravidae: humoral and cellular immune responses to Plasmodium falciparum blood-stage antigens. Am. J. Trop. Med. Hyg. 1995, 53:612-617.
19. Fievet N., et al. Immune response to Plasmodium falciparum antigens in Cameroonian primigravidae: evolution after delivery and during second pregnancy. Clin. Exp. Immunol. 1997, 107:462-467.
20. Rogerson S.J., et al. Chondroitin sulfate A is a cell surface receptor for Plasmodium falciparum-infected erythrocytes. J. Exp. Med. 1995, 182:15-20.
21. Robert C., et al. Chondroitin-4-sulphate (proteoglycan), a receptor for Plasmodium falciparum-infected erythrocyte adherence on brain microvascular endothelial cells. Res. Immunol. 1995, 146:383-393.
22. Williams A.I. Preparation and use of malarial placenta antigen for immunodiffusion studies in a Nigerian population. Trans. R. Soc. Trop. Med. Hyg. 1973, 67:621-630.
23. Bulmer J.N., et al. Placental malaria. I. Pathological classification. Histopathology 1993, 22:211-218.
24. Fried M., Duffy P.E. Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta. Science 1996, 272:1502-1504.
25. Fried M., et al. Maternal antibodies block malaria. Nature 1998, 395:851-852.
26. Beeson J.G., et al. Plasmodium falciparum isolates from infected pregnant women and children are associated with distinct adhesive and antigenic properties. J. Infect. Dis. 1999, 180:464-472.
27. Maubert B., et al. Development of antibodies against chondroitin sulfate A-adherent Plasmodium falciparum in pregnant women. Infect. Immun. 1999, 67:5367-5371.
28. Ricke C.H., et al. Plasma antibodies from malaria-exposed pregnant women recognize variant surface antigens on Plasmodium falciparum-infected erythrocytes in a parity-dependent manner and block parasite adhesion to chondroitin sulfate A. J. Immunol. 2000, 165:3309-3316.
29. O'Neil-Dunne I., et al. Gravidity-dependent production of antibodies that inhibit binding of Plasmodium falciparum-infected erythrocytes to placental chondroitin sulfate proteoglycan during pregnancy. Infect. Immun. 2001, 69:7487-7492.
30. Staalsoe T., et al. Acquisition and decay of antibodies to pregnancy-associated variant antigens on the surface of Plasmodium falciparum-infected erythrocytes that protect against placental parasitemia. J. Infect. Dis. 2001, 184:618-626.
31. Duffy P.E., Fried M. Antibodies that inhibit Plasmodium falciparum adhesion to chondroitin sulfate A are associated with increased birth weight and the gestational age of newborns. Infect. Immun. 2003, 71:6620-6623.
32. Staalsoe T., et al. Variant surface antigen-specific IgG and protection against clinical consequences of pregnancy-associated Plasmodium falciparum malaria. Lancet 2004, 363:283-289.
33. Beeson J.G., et al. Antibodies to variant surface antigens of Plasmodium falciparum-infected erythrocytes and adhesion inhibitory antibodies are associated with placental malaria and have overlapping and distinct targets. J. Infect. Dis. 2004, 189:540-551.
34. Khattab A., et al. Analysis of IgG with specificity for variant surface antigens expressed by placental Plasmodium falciparum isolates. Malar. J. 2004, 3:21.
35. Suguitan A.L., et al. Lack of an association between antibodies to Plasmodium falciparum glycosylphosphatidylinositols and malaria-associated placental changes in Cameroonian women with preterm and full-term deliveries. Infect. Immun. 2004, 72:5267-5273.
36. Mount A.M., et al. Impairment of humoral immunity to Plasmodium falciparum malaria in pregnancy by HIV infection. Lancet 2004, 363:1860-1867.
37. Staalsoe T., et al. Intermittent preventive sulfadoxine-pyrimethamine treatment of primigravidae reduces levels of plasma immunoglobulin G, which protects against pregnancy-associated Plasmodium falciparum malaria. Infect. Immun. 2004, 72:5027-5030.
38. Salanti A., et al. Evidence for the involvement of VAR2CSA in pregnancy-associated malaria. J. Exp. Med. 2004, 200:1197-1203.
39. Cox S.E., et al. Rapid acquisition of isolate-specific antibodies to chondroitin sulfate A-adherent plasmodium falciparum isolates in Ghanaian primigravidae. Infect. Immun. 2005, 73:2841-2847.
40. Megnekou R., et al. Effects of pregnancy and intensity of Plasmodium falciparum transmission on immunoglobulin G subclass responses to variant surface antigens. Infect. Immun. 2005, 73:4112-4118.
41. Elliott S.R., et al. Placental malaria induces variant-specific antibodies of the cytophilic subtypes immunoglobulin G1 (IgG1) and IgG3 that correlate with adhesion inhibitory activity. Infect. Immun. 2005, 73:5903-5907.
42. Beeson J.G., et al. Antigenic differences and conservation among placental Plasmodium falciparum-infected erythrocytes and acquisition of variant-specific and cross-reactive antibodies. J. Infect. Dis. 2006, 193:721-730.
43. Fievet N., et al. Acquisition of antibodies to variant antigens on the surface of Plasmodium falciparum-infected erythrocytes during pregnancy. Infect. Genet. Evol. 2006, 6:459-463.
44. Tuikue Ndam N.G., et al. Dynamics of anti-VAR2CSA immunoglobulin G response in a cohort of senegalese pregnant women. J. Infect. Dis. 2006, 193:713-720.
45. Dahlbäck M., et al. Epitope mapping and topographic analysis of VAR2CSA DBL3X involved in P. falciparum placental sequestration. PLoS Pathog. 2006, 2:e124.
46. Oleinikov A.V., et al. Effects of sex, parity, and sequence variation on seroreactivity to candidate pregnancy malaria vaccine antigens. J. Infect. Dis. 2007, 196:155-164.
47. Keen J., et al. HIV impairs opsonic phagocytic clearance of pregnancy-associated malaria parasites. PLoS Med. 2007, 4:e181.
48. Guitard J., et al. Differential evolution of anti-VAR2CSA IgG3 in primigravidae and multigravidae pregnant women infected by Plasmodium falciparum. Malar. J. 2008, 7:10.
49. Feng G., et al. Antibodies to variant surface antigens of Plasmodium falciparum-infected erythrocytes are associated with protection from treatment failure and the development of anemia in pregnancy. J. Infect. Dis. 2009, 200:299-306.
50. Serra-Casas E., et al. The effect of intermittent preventive treatment during pregnancy on malarial antibodies depends on HIV status and is not associated with poor delivery outcomes. J. Infect. Dis. 2010, 201:123-131.
51. Aitken E.H., et al. Antibodies to chondroitin sulfate A-binding infected erythrocytes: dynamics and protection during pregnancy in women receiving intermittent preventive treatment. J. Infect. Dis. 2010, 201:1316-1325.
52. Brolin K.J.M., et al. Differential recognition of P. falciparum VAR2CSA domains by naturally acquired antibodies in pregnant women from a malaria endemic area. PLoS ONE 2010, 5:e9230.
53. Ataíde R., et al. Using an improved phagocytosis assay to evaluate the effect of HIV on specific antibodies to pregnancy-associated malaria. PLoS ONE 2010, 5:e10807.
54. Aitken E.H., et al. Antibody to P. falciparum in pregnancy varies with intermittent preventive treatment regime and bed net use. PLoS ONE 2012, 7:e29874.
55. Mayor A., et al. Parity and placental infection affect antibody responses against Plasmodium falciparum during pregnancy. Infect. Immun. 2011, 79:1654-1659.
56. Talundzic E., et al. Sequence polymorphism, segmental recombination and toggling amino acid residues within the DBL3X domain of the VAR2CSA placental malaria antigen. PLoS ONE 2012, 7:e31565.
57. Tutterrow Y.L., et al. High levels of antibodies to multiple domains and strains of VAR2CSA correlate with the absence of placental malaria in Cameroonian women living in an area of high Plasmodium falciparum transmission. Infect. Immun. 2012, 80:1479-1490.
58. Tutterrow Y., Lo, et al. High avidity antibodies to full-length VAR2CSA vorrelate with absence of placental malaria. PLoS ONE 2012, 7:e40049.
59. Fowkes F.J.I., et al. New insights into acquisition, boosting, and longevity of immunity to malaria in pregnant women. J. Infect. Dis. 2012, 206:1612-1621.
60. Stewart L., et al. Rapid assessment of malaria transmission using age-specific sero-conversion rates. PLoS ONE 2009, 4:e6083.
61. Warren M., et al. The seroepidemiology of malaria in Middle America. I. Longitudinal studies on populations in a low incidence area of El Salvador. Am. J. Trop. Med. Hyg. 1975, 24:740-748.
62. Warren M., et al. The seroepidemiology of malaria in Middle America. II. Studies on the Pacific coast of Costa Rica. Am. J. Trop. Med. Hyg. 1975, 24:749-754.
63. Warren M., et al. The seroepidemiology of malaria in Middle America. III. Serologic assessment of localized Plasmodium falciparum epidemics. Am. J. Trop. Med. Hyg. 1976, 25:20-25.
64. Drakeley C.J., et al. Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:5108-5113.
65. Ceesay S.J., et al. Continued decline of malaria in The Gambia with implications for elimination. PLoS ONE 2010, 5:e12242.
66. WHO/UNAIDS Reconciling Antenatal Clinic-Based Surveillance and Population-Based Survey Estimates of HIV Prevalence in Sub-Saharan Africa 2003, World Health Organization.
67. Hviid L. The case for PfEMP1-based vaccines to protect pregnant women against Plasmodium falciparum malaria. Expert Rev. Vaccines 2011, 10:1405-1414.
68. Barfod L., et al. Human pregnancy-associated malaria-specific B cells target polymorphic, conformational epitopes in VAR2CSA. Mol. Microbiol. 2007, 63:335-347.
69. Andersen P., et al. Structural insight into epitopes in the pregnancy-associated malaria protein VAR2CSA. PLoS Pathog. 2008, 4:e42.
70. Srivastava A., et al. Full-length extracellular region of the var2CSA variant of PfEMP1 is required for specific, high-affinity binding to CSA. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:4884-4889.
71. Khunrae P., et al. Full-length recombinant Plasmodium falciparum VAR2CSA binds specifically to CSPG and induces potent parasite adhesion-blocking antibodies. J. Mol. Biol. 2010, 397:826-834.
72. Desai M., et al. Epidemiology and burden of malaria in pregnancy. Lancet Infect. Dis. 2007, 7:93-104.
73. Nosten F., et al. Malaria in pregnancy and the endemicity spectrum: what can we learn?. Trends Parasitol. 2004, 20:425-432.
74. González R., et al. HIV and malaria interactions: where do we stand?. Expert Rev. Anti Infect. Ther. 2012, 10:153-165.